Literature DB >> 1326465

Estimation of IgG subclasses of anti-HCV (C100-3) in non-A, non-B fulminant, acute and chronic hepatitis and it's significance.

S M Akbar1, M Onji, Y Ohta.   

Abstract

To determine whether identification of subclasses of anti-HCV IgG would help distinguish between acute and fulminant hepatitis, we assayed serum IgG subclasses of anti-HCV (C100-3) in non-A, non-B hepatitis. Anti-HCV IgG was restricted to two subclasses in different diagnostic conditions; anti-HCV IgG1 and anti-HCV IgG3. Anti-HCV IgG1 was the main subclass in acute hepatitis (AH), and was positive in all the cases and only one case was positive for anti-HCV IgG3. Anti-HCV IgG3 was the dominant subclass in fulminant hepatitis (FH). Out of the total 12 cases of FH, who were positive for either anti-HCV IgG or for any of it's subclasses, in 10 cases (83%), anti-HCV IgG3 had higher optical density (OD) values than anti-HCV IgG1 and in 6 cases (50%) was the only subclass of anti-HCV IgG being positive. In 5 cases with FH, anti-HCV IgG3 became positive even when anti-HCV IgG was negative. These findings from the basis of a new observation and are likely to be helpful in the diagnosis of non-A, non-B fulminant hepatitis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1326465     DOI: 10.1007/bf02777788

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  17 in total

1.  Differentiation between specific and non-specific hepatitis C antibodies in chronic liver disease.

Authors:  J J Gray; T G Wreghitt; P J Friend; D G Wight; V Sundaresan; R Y Calne
Journal:  Lancet       Date:  1990-03-10       Impact factor: 79.321

2.  IgG subclasses in viral infections.

Authors:  F Skvaril
Journal:  Monogr Allergy       Date:  1986

3.  Virus-specific antibody activity of different subclasses of immunoglobulins G and A in cytomegalovirus infections.

Authors:  G A Linde; L Hammarström; M A Persson; C I Smith; V A Sundqvist; B Wahren
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

4.  Acute and chronic hepatitis revisited. Review by an international group.

Authors: 
Journal:  Lancet       Date:  1977-10-29       Impact factor: 79.321

5.  IgG subclass antibodies to herpes simplex virus.

Authors:  R M Coleman; A J Nahmias; S C Williams; D J Phillips; C M Black; C B Reimer
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

6.  Cloning of a cDNA associated with acute and chronic hepatitis C infection generated from patients serum RNA.

Authors:  T Arima; H Nagashima; S Murakami; C Kaji; J Fujita; H Shimomura; T Tsuji
Journal:  Gastroenterol Jpn       Date:  1989-10

7.  The 5'-terminal sequence of the hepatitis C virus genome.

Authors:  H Okamoto; S Okada; Y Sugiyama; S Yotsumoto; T Tanaka; H Yoshizawa; F Tsuda; Y Miyakawa; M Mayumi
Journal:  Jpn J Exp Med       Date:  1990-06

8.  Hepatitis B antigen (HBSAg) and/or antibodies (anti-HBS and anti-HBC) in fulminant hepatitis: pathogenic and prognostic significance.

Authors:  C G Trepo; D Robert; J Motin; D Trepo; M Sepetjian; A M Prince
Journal:  Gut       Date:  1976-01       Impact factor: 23.059

9.  Enhanced HBsAb production in pathogenesis of fulminant viral hepatitis type B.

Authors:  I L Woolf; N El Sheikh; H Cullens; W M Lee; A L Eddleston; R Williams; A J Zuckerman
Journal:  Br Med J       Date:  1976-09-18

10.  Comparison of class and subclass distribution of antibodies to the hepatitis B core and B e antigens in chronic hepatitis B.

Authors:  M Sällberg; H Norder; L O Magnius
Journal:  J Med Virol       Date:  1990-01       Impact factor: 2.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.